Related Experiment Videos
Individualisation of HIV therapy: the clinician's perspective
1Chelsea and Westminster Hospital, London.
The British Journal of Clinical Practice
|May 1, 1995
Summary
Clinical and laboratory markers, including viral load, help personalize HIV treatment. In-vitro data on antiretroviral agents further guide optimal drug selection for effective therapy.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Antiretroviral therapy (ART) is crucial for managing Human Immunodeficiency Virus (HIV) infection.
- Individualizing ART regimens is essential for optimizing patient outcomes and minimizing drug resistance.
Purpose of the Study:
- To evaluate the utility of clinical and laboratory markers in personalizing antiretroviral therapy for HIV.
- To highlight the role of viral load as a key marker for guiding therapeutic decisions.
- To explore the application of in-vitro data in selecting optimal ART regimens.
Main Methods:
- Review of existing data on clinical and laboratory markers in HIV management.
- Analysis of the significance of viral load measurements as baseline and dynamic markers.
- Consideration of in-vitro pharmacokinetic, activity, resistance, and synergy data of antiretroviral agents.
Main Results:
- Clinical and laboratory markers, particularly viral load, are valuable for individualizing HIV therapy.
- Viral load serves as an important marker for both initiating and monitoring treatment effectiveness.
- In-vitro data provides crucial insights into drug selection for potent and synergistic antiretroviral regimens.
Conclusions:
- Personalized antiretroviral therapy for HIV can be effectively guided by clinical and laboratory markers.
- Viral load monitoring is a cornerstone for dynamic therapeutic decision-making in HIV treatment.
- Integrating in-vitro drug data enhances the selection of optimal and effective HIV treatment strategies.